UAB Division of Cardiothoracic Surgery Assistant Professor Panayotis Vardas, M.D., has co-authored the article, "The Society of Thoracic Surgeons 2023 clinical practice guidelines for the surgical ...

LONDON — Updated guidelines for the management of atrial fibrillation released by the European Society of Cardiology are revamping the approach to care for this complex, multifactorial disease. The ...

Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

A major international trial led by the University of British Columbia found that starting treatment with catheter-based pulsed field ablation offers better rhythm control than medication for patients ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial fibrillation is the most common arrhythmia worldwide, affecting millions of the general population.

The second focused update endorses dabigatran (Pradaxa), a new drug that like warfarin represents a first-line choice to prevent thromboembolism in AF. 2 The FDA approved dabigatran in October 2010.

Lone atrial fibrillation is a form of irregular heartbeat that can cause excessively fast beating. It only affects adults under 60 years old and can be asymptomatic or present symptoms, such as a ...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer today announced it expanded its Phase III OCEANIC clinical development program for the investigational drug asundexian (BAY2433334) by initiating a third ...

Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of ...